Libraries of opiate and anti-opiate peptidomimetics containing 2,3-methanoleucine

被引:7
作者
Burgess, K
Li, W
Linthicum, DS
Ni, Q
Pledger, D
Rothman, RB
Shitangkoon, A
机构
[1] TEXAS A&M UNIV, DEPT VET PATHOBIOL, COLLEGE STN, TX 77843 USA
[2] NIDA, CLIN PSYCHOPHARMACOL SECT, DIR, NIH, BALTIMORE, MD 21224 USA
关键词
D O I
10.1016/S0968-0896(97)00117-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A library of 96 peptides/peptidomimetics was prepared, in which half was based on the YGGFL-NH2 sequence, while the remainder were derivatives of a presumed anti-opiate peptide, YGGFLRF-NH2. Of the 48 compounds in each half of the library, 32 contained a stereoisomer of 2,3-methanoleucine substituted for Leu(5). Binding of the YGGFL-NH2 derivatives to the mu- and delta-opioid receptors, and to the anti-beta-endorphin monoclonal antibody (clone 3E7), indicated any change at the Leu(5) had little effect on the binding when compared with modifications to the YGGF-sequence. Conversely, cyclo-Leu residues did alter the binding of YGGFLRF-NH2 derivatives when substituted for Leu(5). Of these 32 peptidomimetics, three derivatives of 2S,3S-cyclo-Leu had relatively low K-i values for binding to an NPFF receptor. Differences between the outcome of the screens were interpreted in terms of the position of the cyclo-Leu residue in the two sequences. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1867 / 1871
页数:5
相关论文
共 27 条
[1]  
BURGESS K, 1994, SYNLETT, P575
[2]   PRACTICAL ASYMMETRIC SYNTHESES OF ALL 4 2,3-METHANOLEUCINE STEREOISOMERS [J].
BURGESS, K ;
LI, W .
TETRAHEDRON LETTERS, 1995, 36 (16) :2725-2728
[3]   CONFORMATIONAL EFFECTS OF SUBSTITUTING METHIONINE WITH (2S,3S)-2,3-METHANOMETHIONINE IN PHE-MET-ARG-PHE-NH2 [J].
BURGESS, K ;
HO, KK ;
PETTITT, BM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (01) :54-65
[4]  
FELIX AM, 1988, INT J PEPT PROT RES, V31, P231
[5]   THE SYNTHESIS, BIOACTIVITY AND ENZYME STABILITY OF D-ALA2, DELEPHE4, LEU5-ENKEPHALINS [J].
KIMURA, H ;
STAMMER, CH ;
SHIMOHIGASHI, Y ;
CUI, RL ;
STEWART, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 115 (01) :112-115
[6]  
KIMURA H, 1983, 8TH P AM PEPT S, P287
[7]  
KUSSIE PH, 1989, METHOD ENZYMOL, V178, P49
[8]  
MAEJI N J, 1991, Peptide Research, V4, P142
[9]   Enhanced antiopiate activity and enzyme resistance in a peptidomimetic of FMRFamide containing E-2,3-methanomethionine and E-2,3-methanophenylalanine [J].
Malin, DH ;
Lake, JR ;
McDermitt, LS ;
Smith, DA ;
Witherspoon, WE ;
Jones, JA ;
Schumann, MD ;
Payza, K ;
Ho, KK ;
Burgess, K .
PEPTIDES, 1996, 17 (01) :83-86
[10]   ENHANCED ANTIOPIATE ACTIVITY IN PEPTIDOMIMETICS OF FMRFAMIDE CONTAINING Z-2,3-METHANOMETHIONINE [J].
MALIN, DH ;
PAYZA, K ;
LAKE, JR ;
CORRIERE, LS ;
BENSON, TM ;
SMITH, DA ;
KELLEY, RS ;
HO, KK ;
BURGESS, K .
PEPTIDES, 1993, 14 (01) :47-51